IP Library Granted Patent US 8,039,223
Granted Patent B2
US 8,039,223 · App. 12/468,440 · Granted Oct 18, 2011

Method of selectively assaying adiponectin multimers

Assignees: Sekisui Medical Co., Ltd.; Toudai TLO, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,223
App. No.
12/468,440
Granted
Oct 18, 2011
Kind
B2
Abstract

Kits and methods for selectively assaying a target adiponectin multimer in a biological sample. Such methods accurately evaluate the relationship between a disease and adiponectin through selective assay of adiponectin multimers and provide information that cannot be obtained through measurement of the total amount of adiponectin alone. A method for selectively assaying a target adiponectin multimer in a biological sample comprising distinguishing target adiponectin multimer from the other adiponectin multimers by using a protease and/or an antibody.

Claims (21)

1. A kit comprising:

(a) a protease which digests ULMW-Ad (ultra low molecular weight adiponectin), LMW-Ad (low molecular weight adiponectin) and MMW-Ad (middle molecular weight adiponectin) multimers; and

(b) an anti-human adiponectin antibody which recognizes adiponectin and which is immobilized on an insoluble carrier.

2. The kit of claim 1 , wherein the protease is derived from a microorganism.

3. The kit of claim 1 , wherein the protease is selected from at least one of proteinase K, protease P “Amano,” protease N “Amano”, and Umamizyme.

4. The kit of claim 1 , wherein the at least one protease includes proteinase K.

5. The kit of claim 1 , wherein the anti-human adiponectin antibody is polyclonal.

6. The kit of claim 1 , wherein the anti-human adiponectin antibody is monoclonal.

7. The kit of claim 1 , wherein the anti-human adiponectin antibody is polyclonal.

8. The kit of claim 1 , wherein the anti-human adiponectin antibody is a goat, mouse or rabbit antibody.

9. The kit of claim 1 , further comprising an enzyme-labeled antibody that recognizes albumin in combination with the carrier.

10. The kit of claim 1 , wherein the anti-human adiponectin antibody recognizes an adiponectin-albumin complex.

11. The kit of claim 1 , which is an ELISA (enzyme linked immunosorbent assay) kit.

12. The kit of claim 1 , which is a kit for CLEIA (chemiluminescent enzyme immunoassay), RIA (radioimmunoassay), or LTIA (latex turbidimetric immunoassay).

13. The kit of claim 1 , further comprising at least one of a reducing agent, an acid or a salt thereof, a surfactant, a stabilizer, or a buffer.

14. The kit of claim 1 , further comprising a biological sample suspected of containing adiponectin.

15. A composition comprising:

(a) a protease which digests ULMW-Ad (ultra low molecular weight adiponectin), LMW-Ad (low molecular weight adiponectin) and MMW-Ad (middle molecular weight adiponectin); and

(b) an anti-human adiponectin antibody which recognizes adiponectin and which is immobilized on an insoluble carrier.

16. The composition of claim 15 , further comprising at least one of a reducing agent, an acid or a salt thereof, a surfactant, or a buffer.

17. The composition of claim 15 , further comprising a biological sample suspected of containing adiponectin.

Assignments (1)
CHANGE OF NAME Recorded Oct 27, 2010
From: DAIICHI PURE CHEMICALS CO., LTD.
To: SEKISUI MEDICAL CO., LTD.
Reel/Frame 025192/0772 →
Priority Claims (1)
JP 2003-354930 · Oct 15, 2003 · national
Continuity (2)
Division 10575931
Related Publication 20090291461A1 · Nov 26, 2009